title: Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine.
abstract: Group B Coxsackieviruses (CVB) are involved in various acute clinical features and they can play a role in the development of chronic diseases like type 1 diabetes. The persistence of CVB has been described in vitro and in vivo in various models. Fluoxetine was reported to inhibit the replication of CVB1-3, which prompted us to study the in vitro antiviral activity of fluoxetine against CVB4 in models of acute infection. In addition we took advantage of a chronically CVB4-infected Panc-1 cell line to evaluate the antiviral effect of fluoxetine in a model of persistent CVB4 infection. An inhibition of the CVB4 replication was obtained when fluoxetine was added at 5.48μM to Hep-2 cell cultures. No inhibitory effect was observed when CVB4 was mixed with fluoxetine for 2h and filtered to eliminate fluoxetine before inoculation to cells, or when cells were treated up to 96h and washed before viral inoculation. Fluoxetine (5.48μM) reduced viral replication by more than 50% in acutely infected Panc-1 cell cultures. A dramatic decrease of infectious particles levels in supernatants of Panc-1 cells chronically infected with CVB4 was obtained a few days after treatment with fluoxetine and no infectious viral particle was found as soon as day 21 of treatment, and intracellular enteroviral RNA was undetectable by RT-PCR after three weeks of treatment. These data display that fluoxetine can inhibit the replication of CVB4 and can cure Panc-1 cells chronically infected with CVB4.
authors: Université Lille 2, Faculté de Médecine, CHRU de Lille, Laboratoire de virologie EA3610, Lille, France.
authors: Enagnon Kazali
authors: EK
authors: Alidjinou
authors: Université Lille 2, Faculté de Médecine, CHRU de Lille, Laboratoire de virologie EA3610, Lille, France.
authors: Famara
authors: F
authors: Sané
authors: Université Lille 2, Faculté de Médecine, CHRU de Lille, Laboratoire de virologie EA3610, Lille, France.
authors: Antoine
authors: A
authors: Bertin
authors: Université Lille 2, Faculté de Médecine, CHRU de Lille, Laboratoire de virologie EA3610, Lille, France.
authors: Delphine
authors: D
authors: Caloone
authors: Université Lille 2, Faculté de Médecine, CHRU de Lille, Laboratoire de virologie EA3610, Lille, France. Electronic address: didier.hober@chru-lille.fr.
authors: Didier
authors: D
authors: Hober
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D029822:Enterovirus B, Human / Q000187:drug effects* / Q000502:physiology; D005473:Fluoxetine / Q000494:pharmacology*; D006801:Humans; D010183:Pancreatic Ducts / Q000821:virology*; D012367:RNA, Viral / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D012367:RNA, Viral; D005473:Fluoxetine
keywords: Antiviral activity; Coxsackievirus B4; Fluoxetine; Persistent infection